Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ICE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C12orf66 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBTPS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GCFC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADNP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARIH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZC3H13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
IGBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EML5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATAD3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSME3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSPA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRPF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM160A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF417 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HEXIM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on